Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Oncopeptides, and Sanofi Genzyme.

Community Practice Connections™: Uncovering New Multiple Myeloma Therapies and Their Clinical Applications: Antibodies, CARs, BiTEs, and Beyond

Release Date: August 31, 2021
Expiration Date: August 31, 2022

Activity Overview

Community Practice ConnectionsTM: Uncovering New Multiple Myeloma Therapies and Their Clinical Applications: Antibodies, CARs, BiTEs, and Beyond consists of a series of short summaries of clinical data and concise video interviews with leading experts in the treatment of patients with relapsed/refractory multiple myeloma (RRMM). The video interviews provide expert perspectives on clinical data and address questions commonly faced in the community oncology practice setting.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Bristol Myers Squibb, Janssen Biotech,, Inc., administered by Janssen Scientific Affairs, LLC, Oncopeptides, and Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward medical oncologists and hematologist/oncologists who treat patients with multiple myeloma.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the impact of disease-specific factors, risk assessment, and treatment history on therapy selection in RRMM
  • Evaluate the safety and efficacy profiles of current and emerging therapies for patients with RRMM
  • Implement proactive strategies to identify and minimize the negative impact of treatment-related toxicities in patents with RRMM
  • Apply updated guidelines and evidence from landmark trials evaluating emerging therapeutic strategies for RRMM to real-world clinical scenarios of patients with this malignancy

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Kenneth C. Anderson, MD
Kenneth C. Anderson, MD
Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Institute Physician, Kraft Family Professor of Medicine, Harvard Medical School
Boston, MA

Disclosures: Stock/Shareholder: Scientific Founder and board member, OncoPep, C4 Therapeutics, Inc.; Consultant: Amgen, AstraZeneca, Bristol Myers Squibb, Janssen, Pfizer, Precision BioSciences

Nina Shah, MD
Nina Shah, MD
Associate Professor, Department of Medicine
University of California
San Francisco, CA

Disclosures: Grant Research Support: bluebird bio, inc., Celgene Corporation, a Bristol Myers Squibb Company, Janssen, Nektar Therapeutics, Poseida Therapeutics, Inc., Sutro Biopharma, Inc., TeneoBio; Consultant: Amgen, Bristol Myers Squibb, CareDx, CSL Behring, GSK, Indapta Therapeutics, Karyopharm Therapeutics, Kite Pharma, a Gilead Company, Sanofi

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By